GlaxoSmithKline announces clinical trials of Ebola vaccine 'later this year'

15th August 2014

Current outbreak in Africa has killed nearly 1,000 people, prompting an international health emergency to be declared.

An experimental vaccine against the deadly Ebola virus will soon go into clinical trial, according to the British drugmaker GlaxoSmithKline, which is developing it with scientists at the US National Institute of Allergy and Infectious Diseases (NIAID).


Leave a Reply

Your email address will not be published.

− 5 = 1

« back to posts